Final One-Year Results of the CAUSMIC Trial
First United States Randomized Controlled
Trial Utilizing 3-Dimensional,
Catheter-Based
Delivery of Autologous
Skeletal
Myoblasts
for Ischemic
Cardiomyopathy
Nabil Dib, M.D., MSc, FACC
Director, Cardiovascular Research
Mercy Gilbert Medical Center
Chandler Regional Medical Center
Director, Clinical Cardiovascular Cell Therapy
University of California, San Diego